Inhibrx Biosciences, Inc. (INBX) — Defensive Interval Ratio
Inhibrx Biosciences, Inc. (INBX) has a Defensive Interval Ratio of 3 days as of March 2026. Defensive assets of $186.00K (cash $-, short-term investments $-, receivables $186.00K) cover 3 days of daily cash needs of $72.64K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Inhibrx Biosciences, Inc. Defensive Interval Ratio (2017–2025)
This chart shows how Inhibrx Biosciences, Inc.'s Defensive Interval Ratio has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 3 days, meaning defensive assets of $186.00K can fund 3 days of operations without new revenue. For the complete balance sheet picture, see INBX asset base.
Annual Defensive Interval Ratio for Inhibrx Biosciences, Inc. (2017–2025)
The table below presents the year-by-year Defensive Interval Ratio for Inhibrx Biosciences, Inc. from 2017 to 2025, covering 9 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Inhibrx Biosciences, Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2 days | $177.00K | $92.60K/day | $- | $- | ▼ -2 days |
| 2024 | 4 days | $420.00K | $111.59K/day | $- | $- | ▼ -1 days |
| 2023 | 5 days | $778.00K | $154.28K/day | $- | $- | ▲ +2 days |
| 2022 | 3 days | $257.00K | $75.55K/day | $- | $- | ▼ -11 days |
| 2021 | 14 days | $878.00K | $61.52K/day | $- | $- | ▲ +7 days |
| 2020 | 7 days | $615.00K | $86.02K/day | $- | $- | ▼ -1 days |
| 2019 | 8 days | $438.00K | $56.36K/day | $- | $- | ▼ -8 days |
| 2018 | 16 days | $690.00K | $44.33K/day | $- | $- | ▼ -13 days |
| 2017 | 28 days | $696.00K | $24.44K/day | $- | $- | — |